Valvular & structural heart disease

Hemodynamic Effects of Transcatheter Tricuspid Valve Annuloplasty With Cardioband and Their Associations With Clinical Outcomes

Circ Cardiovasc IntervPublished retrospectively analyzed consecutive patients

Authors' conclusion

Postprocedural XV height was independently associated with 2-year survival and linked to TR reduction and right ventricle remodeling. TTVA improves hemodynamics even in advanced TR, and hemodynamic markers may support risk stratification.

Study context

Population
Patients with severe functional tricuspid regurgitation (TR) who underwent transcatheter tricuspid valve annuloplasty (TTVA) with the Cardioband system between 2019 and 2022patients with complete hemodynamic assessment
Participants
58 patients
Exposure
Hemodynamics before vs after cinching
Outcome
2-year survival
Follow-up
2 years
Methodological detailsretrospective
  • Retrospective

Main finding

As reported in the abstract

Lower postprocedural XV height independently predicted 2-year survival
P =0.002
Immediate right ventricle remodeling associated with 2-year survival
P =0.024

Observational data: associations, not effects.

Further findings

Baseline TR grade

Torrential
40%
Severe
38%
Massive
22%

TR reduction

Reduced by ≥2 grades
83%
Reduced by ≥1 grade
97%

Hemodynamics following TTVA

Median cardiac index
2.4-2.8 L/[min·m²]
Pulmonary artery pulsatility index
1.73-2.13
Right ventricle cardiac power index
0.15-0.21 W/m²
XV height
12.5 to 7 mm Hg; P <0.001
Right atrial pressure (mean/V-wave) decreased significantly

Postprocedural XV height associations

Lower TR grade at follow-up
P = 0.002
Right ventricle reverse remodeling
P < 0.001

Original publication

Hemodynamic Effects of Transcatheter Tricuspid Valve Annuloplasty With Cardioband and Their Associations With Clinical Outcomes. Circ Cardiovasc Interv. Published 1 September 2025. doi:10.1161/circinterventions.125.015702

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.